<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : Cannabis</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 25 Oct 2007 07:48:36 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Increase in psychotic symptoms predicts relapse to cannabis use</title>
        <link>http://www.rxpgnews.com/cannabis/Increase_in_psychotic_symptoms_predicts_relapse_to_4805_4805.shtml</link>
        <category>Cannabis</category>
        <description>There may be a two-way relationship between cannabis use and psychosis, according to a new study from Australia. Published in the August issue of the British Journal of Psychiatry, the study found that more frequent cannabis use was associated with a higher risk of psychotic relapse, and more severe psychotic symptoms were associated with increased risk of cannabis relapse.</description>
        <pubDate>Wed, 09 Aug 2006 12:41:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/cannabis/Increase_in_psychotic_symptoms_predicts_relapse_to_4805_4805.shtml</guid>
      </item>
      <item>
        <title>New PET Radiotracer to Visualize Cannabinoid Receptors Developed</title>
        <link>http://www.rxpgnews.com/cannabis/New_PET_Radiotracer_to_Visualize_Cannabinoid_Recep_4393_4393.shtml</link>
        <category>Cannabis</category>
        <description>A team of Johns Hopkins researchers developed a new radiotracera radioactive substance that can be traced in the bodyto visualize and quantify the brains cannabinoid receptors by positron emission tomography (PET), opening a door to the development of new medications to treat drug dependence, obesity, depression, schizophrenia, Parkinsons disease and Tourette syndrome.</description>
        <pubDate>Tue, 06 Jun 2006 23:56:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/cannabis/New_PET_Radiotracer_to_Visualize_Cannabinoid_Recep_4393_4393.shtml</guid>
      </item>
      <item>
        <title>Cannabis Based Medicine to be Supplied in Spain</title>
        <link>http://www.rxpgnews.com/cannabis/Cannabis_Based_Medicine_to_be_Supplied_in_Spain_2809_2809.shtml</link>
        <category>Cannabis</category>
        <description>GW Pharmaceuticals is today pleased to announce that it has reached agreement with the Health Department of The Regional Government of Catalonia in Spain to supply Sativex ® oromucosal spray, its cannabis-based medicine, to 600 patients suffering from Multiple Sclerosis and a number of other conditions under a compassionate access programme.</description>
        <pubDate>Tue, 08 Nov 2005 21:29:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/cannabis/Cannabis_Based_Medicine_to_be_Supplied_in_Spain_2809_2809.shtml</guid>
      </item>
      <item>
        <title>Call for public health campaign on cannabis</title>
        <link>http://www.rxpgnews.com/cannabis/Call_for_public_health_campaign_on_cannabis_2511_2511.shtml</link>
        <category>Cannabis</category>
        <description>The mental healthy charity Rethink on September 23 gave evidence to the Advisory Council on the Mis-use of Drugs, which is considering the classification of cannabis at the request of the Home Secretary and called for a long-term, properly funded public health campaign highlighting the mental health dangers of using cannabis.</description>
        <pubDate>Wed, 28 Sep 2005 07:51:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/cannabis/Call_for_public_health_campaign_on_cannabis_2511_2511.shtml</guid>
      </item>
      <item>
        <title>Canada approved Cannabis extract Based Drug</title>
        <link>http://www.rxpgnews.com/cannabis/Canada_approved_Cannabis_extract_Based_Drug_1201_1201.shtml</link>
        <category>Cannabis</category>
        <description>Health Canada has approved Sativex® (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS).</description>
        <pubDate>Thu, 21 Apr 2005 17:31:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/cannabis/Canada_approved_Cannabis_extract_Based_Drug_1201_1201.shtml</guid>
      </item>


  </channel>
</rss>
